Alzheimer's disease is marked by toxic amyloid-beta protein clumps, but some people seem naturally protected. A new study reveals that a receptor called ADGRG1 enables immune cells called microglia to effectively clear these harmful plaques.
Alzheimer's disease is marked by toxic amyloid-beta protein clumps, but some people seem naturally protected. A new study reveals that a receptor called ADGRG1 enables immune cells called microglia to effectively clear these harmful plaques.